606
Views
20
CrossRef citations to date
0
Altmetric
Case Report

Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19

, , , , , , , , , , & show all
Pages 382-385 | Received 16 Jan 2021, Accepted 09 Feb 2021, Published online: 01 Mar 2021

References

  • Petrosillo N, Viceconte G, Ergonul O, et al. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020;26(6):729–734.
  • Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275.
  • Haglund A, Christensen S, Kristensen L, et al. Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19. Med Mycol Case Rep. 2020.
  • Meersseman W, Vandecasteele SJ, Wilmer A, et al. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004;170(6):621–625.
  • Beumer MC, Koch RM, van Beuningen D, et al. Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality. J Crit Care. 2019;50:59–65.
  • Menon AA, Berg DD, Brea EJ, et al. A case of COVID-19 and Pneumocystis jirovecii coinfection. Am J Respir Crit Care Med. 2020;202(1):136–138. 01,
  • Bhat P, Noval M, Doub JB, et al. Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient. Int J Infect Dis. 2020;99:119–121.
  • Guo W, Wang M, Ming F, et al. The diagnostic trap occurred in two COVID-19 cases combined pneumocystis pneumonia in patient with AIDS. Res Sq. 2020.
  • Mang S, Kaddu-Mulindwa D, Metz C, et al. Pneumocystis jirovecii pneumonia and severe acute respiratory syndrome coronavirus 2 coinfection in a patient with newly diagnosed HIV-1 infection. Clin Infect Dis. 2020.
  • De Francesco MA, Alberici F, Bossini N, et al. Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: a common feature in transplant recipients? Vaccines. 2020;8(3):544.
  • Alanio A, Dellière S, Voicu S, et al. The presence of Pneumocystis jirovecii in critically ill patients with COVID-19. J Infect. 2020.
  • Rosas J, Liañob FP, Cantóc ML, et al. Experiencia con el uso de baricitinib y tocilizumab en monoterapia o combinados, en pacientes con neumonía intersticial secundaria al coronavirus COVID19: un estudio del mundo real. Reumatol Clín. 2020.
  • Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–1376.
  • Sun HB, Zhang YM, Huang LG, et al. The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19. PLoS One. 2020;15(9):e0239532.
  • The Recovery Collaborative Group. Dexamethasone in hospitalized patients with covid-19—preliminary report. N Engl J Med. 2020.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.